ZNF461: A Potential Drug Target for Fertility (G92283)
![Review Report on ZNF461 Target / Biomarker](https://silexon.ai/img/target-biomarker-review.jpg?a=1)
![Content of Review Report on ZNF461 Target / Biomarker](https://silexon.ai/img/target-biomarker-review-content.jpg?a=2)
ZNF461: A Potential Drug Target for Fertility
Gonadotropin-inducible ovary transcription repressor 1 (ZNF461) is a non-coding RNA molecule that is expressed in the ovaries of females and is involved in the regulation of ovarian development and function. ZNF461 has been identified as a potential drug target and has been the focus of research in the field of gonadotropin signaling and reproductive biology.
History of ZNF461 Research
ZNF461 was first identified in the genomic sequence of the mouse in 2004 by researchers at the University of California, Irvine. The gene was later identified in several other species, including humans, and its function was found to be involved in the regulation of ovarian development and maintenance.
The discovery of ZNF461 has led to a significant amount of research on its role in gonadotropin signaling and reproductive biology. Studies have shown that ZNF461 plays a crucial role in the regulation of ovarian stem cell proliferation and differentiation, as well as the control of ovarian gene expression.
Potential Drug Target
The potential drug target for ZNF461 is its role in gonadotropin signaling and its involvement in the regulation of ovarian development and maintenance. Gonadotropin is a hormone that plays a critical role in the development and function of the gonads, including the ovaries and testes. It is produced by the pituitary gland and plays a vital role in the regulation of sexual function in females.
Research has shown that ZNF461 is involved in the regulation of gonadotropin signaling and its role in the regulation of ovarian development and maintenance. Studies have shown that overexpression of ZNF461 can lead to decreased levels of gonadotropin in the ovaries, which can result in decreased fertility.
Additionally, ZNF461 has also been shown to play a role in the regulation of stem cell proliferation and differentiation. This suggests that it may be a potential drug target for therapies aimed at enhancing fertility in women.
Mechanism of Action
The mechanism of action of ZNF461 is not well understood, but it is thought to be involved in the regulation of gonadotropin signaling and its role in the regulation of ovarian development and maintenance.
One possible mechanism of action for ZNF461 is its ability to interact with and inhibit the activity of the protein TrkA, which is a key component of the gonadotropin signaling pathway. TrkA is thought to play a role in the regulation of stem cell proliferation and differentiation, and ZNF461 may be involved in its regulation.
Another potential mechanism of action for ZNF461 is its ability to interact with and modulate the activity of the protein YAP/TAZ, which is also involved in the regulation of stem cell proliferation and differentiation.
Conclusion
ZNF461 is a non-coding RNA molecule that is involved in the regulation of ovarian development and maintenance. Its potential drug target status and involvement in gonadotropin signaling make it an attractive target for further research and the development of therapies aimed at enhancing fertility in women. Further studies are needed to fully understand the mechanism of action and role of ZNF461 in gonadotropin signaling and reproductive biology.
Protein Name: Zinc Finger Protein 461
Functions: May be involved in transcriptional regulation
The "ZNF461 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF461 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
ZNF462 | ZNF467 | ZNF468 | ZNF469 | ZNF470 | ZNF471 | ZNF473 | ZNF473CR | ZNF479 | ZNF48 | ZNF480 | ZNF483 | ZNF484 | ZNF485 | ZNF486 | ZNF487 | ZNF488 | ZNF490 | ZNF491 | ZNF492 | ZNF493 | ZNF496 | ZNF497 | ZNF497-AS1 | ZNF500 | ZNF501 | ZNF502 | ZNF503 | ZNF503-AS1 | ZNF503-AS2 | ZNF506 | ZNF507 | ZNF510 | ZNF511 | ZNF512 | ZNF512B | ZNF513 | ZNF514 | ZNF516 | ZNF516-DT | ZNF517 | ZNF518A | ZNF518B | ZNF519 | ZNF519P3 | ZNF521 | ZNF524 | ZNF525 | ZNF526 | ZNF527 | ZNF528 | ZNF528-AS1 | ZNF529 | ZNF529-AS1 | ZNF530 | ZNF532 | ZNF534 | ZNF536 | ZNF540 | ZNF541 | ZNF542P | ZNF543 | ZNF544 | ZNF546 | ZNF547 | ZNF548 | ZNF549 | ZNF550 | ZNF551 | ZNF552 | ZNF554 | ZNF555 | ZNF556 | ZNF557 | ZNF558 | ZNF559 | ZNF559-ZNF177 | ZNF560 | ZNF561 | ZNF561-AS1 | ZNF562 | ZNF563 | ZNF564 | ZNF565 | ZNF566 | ZNF566-AS1 | ZNF567 | ZNF568 | ZNF569 | ZNF56P | ZNF57 | ZNF570 | ZNF571 | ZNF571-AS1 | ZNF572 | ZNF573 | ZNF574 | ZNF575 | ZNF576 | ZNF577